[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100492558":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":34,"locations":43,"responsibleParty":63,"collaborators":66,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":72,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":25,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":90,"overallStatus":46,"whyStopped":25,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"University of Texas Southwestern Medical Center","OTHER",[8,13],{"label":9,"type":6,"description":10,"interventionNames":11},"Control group (Usual care)","This arm will receive standard notification that is usually provided by Carter describing need to review with donor's primary care physician the presence of high cholesterol",[12],"Other: Usual care notification",{"label":14,"type":15,"description":16,"interventionNames":17},"Intervention Group (Implementation strategy bundle)","EXPERIMENTAL","Along with standard high cholesterol notification from Carter BloodCare, this arm will receive Implementation strategy bundle (educational material regarding high cholesterol levels)",[18,12],"Behavioral: Implementation Strategy Bundle",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","Implementation Strategy Bundle","Bundle includes multimodal communications to notify donors about high cholesterol and its treatment, website with resources, and an optional care navigator. Resources for their primary care provider will also be disseminated.",[14],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Usual care notification","Carter BloodCare will notify participants of their high cholesterol, potential for genetic causes, and recommendation to see their care provider by sending its routine, standard notification letter. These participants will also be eligible to receive the intervention bundle at the end of the study.",[9,14],[31],{"name":32,"affiliation":5,"role":33},"Amit Khera, MD","PRINCIPAL_INVESTIGATOR",[35,39],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},"CONTACT","214.645.7500","Amit.Khera@UTSouthwestern.edu",{"name":40,"role":36,"phone":41,"phoneExt":25,"email":42},"Lakeisha Cade","214.648.2878","Lakeisha.Cade@UTSouthwestern.edu",[44],{"facility":45,"status":46,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"UT Southwestern Medical Center","RECRUITING","Dallas","Texas","75390","United States","US",{"type":53,"coordinates":54},"Point",[55,56],-96.80667,32.78306,{"lat":56,"lon":55},[59,61,62],{"name":40,"role":36,"phone":41,"phoneExt":25,"email":60},"BloodDonorStudy@UTSouthwestern.edu",{"name":32,"role":36,"phone":25,"phoneExt":25,"email":60},{"name":32,"role":33,"phone":25,"phoneExt":25,"email":25},{"type":33,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Amit Khera","PROFESSOR - Internal Medicine",[67],{"name":68,"class":69},"National Heart, Lung, and Blood Institute (NHLBI)","NIH","100492558","multicomponent-intervention-study--blood-donors-with-high-cholesterol-100492558",false,"NCT05693701","Multicomponent Intervention Study- Blood Donors With High Cholesterol","Implementing a Multicomponent Intervention to Treat Blood Donors With Familial Hypercholesterolemia","DONATE-FH","Inclusion Criteria:\n\n* Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria\n* Age 18 to 75 years\n\nExclusion Criteria:\n\n* Currently taking medication to lower cholesterol\n* Taking any medication that can interact with statins\n* Pregnancy\n* Identified secondary cause of elevated lipids\n* Chronic liver disease or significantly elevated liver function tests (\\> 3 times upper limit)","ALL","18 Years","75 Years",{"count":82,"type":83},100,"ESTIMATED","INTERVENTIONAL",[86],"NA","The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).",[89],"Lipid Metabolism Disorder",[91,92,93],"Blood Donors","High Cholesterol","LDL Cholesterol","2026-03-13",{"date":96,"type":97},"2026-03-17","ACTUAL",{"date":99,"type":97},"2023-02-27",{"date":101,"type":83},"2027-04-30",{"name":5,"class":6},1]